Oculus Innovative Sciences Inc. (NASDAQ:OCLS) shot up 2.7% during mid-day trading on Wednesday . The company traded as high as $4.77 and last traded at $4.25, with a volume of 122,980 shares trading hands. The stock had previously closed at $4.14.

A number of research firms have issued reports on OCLS. Zacks Investment Research downgraded Oculus Innovative Sciences from a “hold” rating to a “sell” rating in a research note on Wednesday, March 16th. Maxim Group reiterated a “buy” rating and set a $3.00 price objective on shares of Oculus Innovative Sciences in a research note on Wednesday, April 20th.

The company has a 50-day moving average price of $4.63 and a 200-day moving average price of $4.99. The firm’s market cap is $18.09 million.

Oculus Innovative Sciences (NASDAQ:OCLS) last released its quarterly earnings results on Thursday, June 16th. The company reported ($0.16) EPS for the quarter. Equities analysts anticipate that Oculus Innovative Sciences Inc. will post ($0.37) earnings per share for the current year.

Oculus Innovative Sciences, Inc is a specialty device and pharmaceutical company. The Company develops and markets solutions for the treatment of dermatological conditions and advanced tissue care in both humans and animals. The Company offers wound care products which are sold into the human and animal healthcare markets in the United States, Mexico and Europe.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.